Sarcoidosis, Cardiac
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS) (NCT07604220) | Mayo Clinic | 2026-07-13 |
| A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis (NCT05351554) | Kinevant Sciences GmbH | 2022-08-23 |
Track Sarcoidosis, Cardiac automatically
Every clearance here is in the API, with alerts when new ones post.